Analyst Ratings for First Tracks Biotherapeutics (TRAX)
TRAX Rating Summary
TRAX Price Target Summary
- Highest: $54.00 (Piper Sandler)
- Lowest: $30.00 (Wedbush)
- Average: $38.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$38.25 (+116.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
30.00 (N/A) |
18.20 (17.64) |
-3.08% | Details |
| 5/4/2026 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
54.00 (N/A) |
23.27 (17.64) |
-24.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
